Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Neoplasms, Basal Cell × BF-200 ALA × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms, Basal Cell 1 Carcinoma, Basal Cell 1

Interventions

methyl 5-aminolevulinate 1 folfirinox 1 Taxes 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Gemcitabine 1 Fluorouracil 1 Erlotinib Hydrochloride 1 BF-200 ALA 1 Aminolevulinic Acid 1 Albumin-Bound Paclitaxel 1 5-aminolevulinic acid hexyl ester 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02367547 2019-03-28

Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL

Joint Authority for Päijät-Häme Social and Health Care

Phase 1/2 Unknown

Carcinoma, Basal Cell, Neoplasms, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡